Skip to content

Analysis of treatment and prognostic outcomes in patients with livedoid vasculopathy: a real-world study

Analysis of treatment and prognostic outcomes in patients with livedoid vasculopathy: a real-world study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095338
Enrollment
Unknown
Registered
2025-01-06
Start date
2024-03-15
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Livedoid vasculopathy

Interventions

Observation group:None

Sponsors

Department of Dermatology, the First Afilinted Hospital of the Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Age 8-70 years old (including 8 and 70 years old), gender is not limited; (2) The clinical and pathological manifestations were consistent with the characteristics of pelotoid angiopathy.

Exclusion criteria

Exclusion criteria: (1) Language or communication barriers, unable to complete the questionnaire; (2) Combined with other serious skin diseases; (3) Refusal to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Semi-quantitative clinical score;

Secondary

MeasureTime frame
Visual Analogue Scale;Dermatological Quality of Life Index;Frequency and recurrence of disease;

Countries

China

Contacts

Public ContactWang Lei

Department of Dermatology, the First Afilinted Hospital of the Air Force Medical University

Wangleidermatology@qq.com+86 139 9131 5632

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026